Your session is about to expire
← Back to Search
Team Intervention Arm for Opioid Use Disorder
Study Summary
This trial is testing a new intervention for people who have overdosed on opioids to see if it can help decrease the number of subsequent overdoses and increase the likelihood of remission from opioid use disorder.
- Opioid Use Disorder
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are participants still being enrolled for this research?
"Contrary to the initial expectations, clinicaltrials.gov indicates that this trial is not presently open for recruitment; although it was initially posted on July 1st 2020 and last updated on November 9th 2022. However, 535 other trials are currently inviting candidates to participate in their study."
Does this research endeavor include elderly individuals in its sample population?
"As indicated by the eligibility criteria, patients must be between 18 and 130 years old to participate in this trial. Simultaneously, 89 trials are available for those under 18 while 400 exist for geriatric citizens above 65."
Am I eligible to be part of this clinical experiment?
"This clinical trial is available to 81 individuals aged 18-130 who are currently struggling with substance abuse. In order to be eligible, participants must not possess any non-opioid related conditions that could explain their decreased level of consciousness, miosis or respiration rate; as well as not being in a critical state at the time of consent (e.g., actively suicidal, psychotic, septic or cardiac arrest). Furthermore, if the prospective participant were discharged from hospital within 7 days prior to joining this study they must meet criteria 3., 4., & 6. Additionally all applicants need to be above the age of majority and able to self"
What objectives are the researchers striving to accomplish with this experiment?
"This trial, monitored over 6 months post-intervention, is primarily concerned with evaluating the occurrence of positive urine tests at 30 days (as reported by patients). Secondary objectives include assessing the percentage of these evaluations within 180 days via self-report and chart review."
Share this study with friends
Copy Link
Messenger